Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD

Detalhes bibliográficos
Autor(a) principal: Canto, Nívea Dias do
Data de Publicação: 2012
Outros Autores: Ribeiro, Jorge Pinto, Neder, José Alberto [UNIFESP], Chiappa, Gaspar Rogério da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
dARK ID: ark:/48912/001300000g8p8
Texto Completo: http://dx.doi.org/10.1016/j.rmed.2012.05.012
http://repositorio.unifesp.br/handle/11600/35301
Resumo: Background: the addition of tiotropium bromide (110) to formoterol fumarate (FOR) improves exercise performance in patients with chronic obstructive pulmonary disease (COPD). in this study, we test the hypothesis that the addition of TIO to for may improve respiratory muscle performance and oxygen uptake kinetics after exercise in patients with COPD.Methods: Thirty eight patients with COPD were randomized to a 2 week treatment with for 12 mu g twice a day plus TIO 18 mu g once a day (FOR + TIO) or for 12 mu g twice a day plus placebo (FOR + PLA) once a day, using a double-blind crossover design. Inspiratory muscle. Strength was measured before, immediately after, as well as 2, 5, and 10 min during recovery of exercise. Time to limit of tolerance on a constant work load exercise test and oxygen uptake kinetics during recovery were evaluated before and after intervention.Results: Only for + TIO improved resting (63 +/- 10 cm to 84 +/- 11 cmH(2)O) and post-exercise (49 +/- 7 cm to 84 +/- 11 cmH(2)O) maximal inspiratory pressure. Time to limit of tolerance on the constant work load test was increased by for + PLA and by for + TIO, but the size of the increment was significantly larger with for + TIO (40.7 +/- 7.6% vs. 84.5 +/- 8.2%; p < 0.05). Only for + TIO improved oxygen uptake kinetics during recovery (69 +/- 21 to 60 +/- 18s). the improvement in maximal inspiratory pressure (0.78, p < 0.001) and in oxygen uptake kinetics (-0.91, p < 0.001) correlated with the change in time to the limit of tolerance.Conclusions: the addition of TIO to for improves inspiratory muscle strength and oxygen uptake kinetics after exercise in COPD patients. (C) 2012 Elsevier B.V. All rights reserved.
id UFSP_55949b873d08c15381a295f6f8298389
oai_identifier_str oai:repositorio.unifesp.br/:11600/35301
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPDRespiratory musclesOxygenInspiratory muscle strengthConstant work testBackground: the addition of tiotropium bromide (110) to formoterol fumarate (FOR) improves exercise performance in patients with chronic obstructive pulmonary disease (COPD). in this study, we test the hypothesis that the addition of TIO to for may improve respiratory muscle performance and oxygen uptake kinetics after exercise in patients with COPD.Methods: Thirty eight patients with COPD were randomized to a 2 week treatment with for 12 mu g twice a day plus TIO 18 mu g once a day (FOR + TIO) or for 12 mu g twice a day plus placebo (FOR + PLA) once a day, using a double-blind crossover design. Inspiratory muscle. Strength was measured before, immediately after, as well as 2, 5, and 10 min during recovery of exercise. Time to limit of tolerance on a constant work load exercise test and oxygen uptake kinetics during recovery were evaluated before and after intervention.Results: Only for + TIO improved resting (63 +/- 10 cm to 84 +/- 11 cmH(2)O) and post-exercise (49 +/- 7 cm to 84 +/- 11 cmH(2)O) maximal inspiratory pressure. Time to limit of tolerance on the constant work load test was increased by for + PLA and by for + TIO, but the size of the increment was significantly larger with for + TIO (40.7 +/- 7.6% vs. 84.5 +/- 8.2%; p < 0.05). Only for + TIO improved oxygen uptake kinetics during recovery (69 +/- 21 to 60 +/- 18s). the improvement in maximal inspiratory pressure (0.78, p < 0.001) and in oxygen uptake kinetics (-0.91, p < 0.001) correlated with the change in time to the limit of tolerance.Conclusions: the addition of TIO to for improves inspiratory muscle strength and oxygen uptake kinetics after exercise in COPD patients. (C) 2012 Elsevier B.V. All rights reserved.Hosp Clin Porto Alegre, Exercise Pathophysiol Res Lab, Porto Alegre, RS, BrazilHosp Clin Porto Alegre, Div Cardiol, Porto Alegre, RS, BrazilUniv So Santa Catarina, Exercise Biochem & Physiol Lab, Postgrad Program Hlth Sci, Hlth Sci Unit, Criciuma, BrazilUniv Fed Rio Grande do Sul, Dept Med, Fac Med, Porto Alegre, RS, BrazilUniversidade Federal de São Paulo, Pulm Funct & Clin Exercise Physiol Unit SEFICE, Div Resp, Dept Med, São Paulo, BrazilPaulista Sch Med UNIFESP EPM, São Paulo, BrazilUniversidade Federal de São Paulo, Pulm Funct & Clin Exercise Physiol Unit SEFICE, Div Resp, Dept Med, São Paulo, BrazilPaulista Sch Med UNIFESP EPM, São Paulo, BrazilWeb of ScienceConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)W B Saunders Co LtdHosp Clin Porto AlegreUniv So Santa CatarinaUniv Fed Rio Grande do SulUniversidade Federal de São Paulo (UNIFESP)Canto, Nívea Dias doRibeiro, Jorge PintoNeder, José Alberto [UNIFESP]Chiappa, Gaspar Rogério da2016-01-24T14:27:44Z2016-01-24T14:27:44Z2012-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1404-1412application/pdfhttp://dx.doi.org/10.1016/j.rmed.2012.05.012Respiratory Medicine. London: W B Saunders Co Ltd, v. 106, n. 10, p. 1404-1412, 2012.10.1016/j.rmed.2012.05.012WOS000309147400008.pdf0954-6111http://repositorio.unifesp.br/handle/11600/35301WOS:000309147400008ark:/48912/001300000g8p8engRespiratory Medicineinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T02:55:28Zoai:repositorio.unifesp.br/:11600/35301Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:16:36.452688Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
title Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
spellingShingle Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
Canto, Nívea Dias do
Respiratory muscles
Oxygen
Inspiratory muscle strength
Constant work test
title_short Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
title_full Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
title_fullStr Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
title_full_unstemmed Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
title_sort Addition of tiotropium to formoterol improves inspiratory muscle strength after exercise in COPD
author Canto, Nívea Dias do
author_facet Canto, Nívea Dias do
Ribeiro, Jorge Pinto
Neder, José Alberto [UNIFESP]
Chiappa, Gaspar Rogério da
author_role author
author2 Ribeiro, Jorge Pinto
Neder, José Alberto [UNIFESP]
Chiappa, Gaspar Rogério da
author2_role author
author
author
dc.contributor.none.fl_str_mv Hosp Clin Porto Alegre
Univ So Santa Catarina
Univ Fed Rio Grande do Sul
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Canto, Nívea Dias do
Ribeiro, Jorge Pinto
Neder, José Alberto [UNIFESP]
Chiappa, Gaspar Rogério da
dc.subject.por.fl_str_mv Respiratory muscles
Oxygen
Inspiratory muscle strength
Constant work test
topic Respiratory muscles
Oxygen
Inspiratory muscle strength
Constant work test
description Background: the addition of tiotropium bromide (110) to formoterol fumarate (FOR) improves exercise performance in patients with chronic obstructive pulmonary disease (COPD). in this study, we test the hypothesis that the addition of TIO to for may improve respiratory muscle performance and oxygen uptake kinetics after exercise in patients with COPD.Methods: Thirty eight patients with COPD were randomized to a 2 week treatment with for 12 mu g twice a day plus TIO 18 mu g once a day (FOR + TIO) or for 12 mu g twice a day plus placebo (FOR + PLA) once a day, using a double-blind crossover design. Inspiratory muscle. Strength was measured before, immediately after, as well as 2, 5, and 10 min during recovery of exercise. Time to limit of tolerance on a constant work load exercise test and oxygen uptake kinetics during recovery were evaluated before and after intervention.Results: Only for + TIO improved resting (63 +/- 10 cm to 84 +/- 11 cmH(2)O) and post-exercise (49 +/- 7 cm to 84 +/- 11 cmH(2)O) maximal inspiratory pressure. Time to limit of tolerance on the constant work load test was increased by for + PLA and by for + TIO, but the size of the increment was significantly larger with for + TIO (40.7 +/- 7.6% vs. 84.5 +/- 8.2%; p < 0.05). Only for + TIO improved oxygen uptake kinetics during recovery (69 +/- 21 to 60 +/- 18s). the improvement in maximal inspiratory pressure (0.78, p < 0.001) and in oxygen uptake kinetics (-0.91, p < 0.001) correlated with the change in time to the limit of tolerance.Conclusions: the addition of TIO to for improves inspiratory muscle strength and oxygen uptake kinetics after exercise in COPD patients. (C) 2012 Elsevier B.V. All rights reserved.
publishDate 2012
dc.date.none.fl_str_mv 2012-10-01
2016-01-24T14:27:44Z
2016-01-24T14:27:44Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.rmed.2012.05.012
Respiratory Medicine. London: W B Saunders Co Ltd, v. 106, n. 10, p. 1404-1412, 2012.
10.1016/j.rmed.2012.05.012
WOS000309147400008.pdf
0954-6111
http://repositorio.unifesp.br/handle/11600/35301
WOS:000309147400008
dc.identifier.dark.fl_str_mv ark:/48912/001300000g8p8
url http://dx.doi.org/10.1016/j.rmed.2012.05.012
http://repositorio.unifesp.br/handle/11600/35301
identifier_str_mv Respiratory Medicine. London: W B Saunders Co Ltd, v. 106, n. 10, p. 1404-1412, 2012.
10.1016/j.rmed.2012.05.012
WOS000309147400008.pdf
0954-6111
WOS:000309147400008
ark:/48912/001300000g8p8
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Respiratory Medicine
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1404-1412
application/pdf
dc.publisher.none.fl_str_mv W B Saunders Co Ltd
publisher.none.fl_str_mv W B Saunders Co Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1818602460212625408